Capitala Group has invested in Novellum Longevity, a company focused on managing wellness clinics, to capitalize on the growing demand for preventative healthcare solutions.

Target Company Overview

Capitala Group, a prominent private markets investment firm, has made a significant senior debt and equity co-investment in Novellum Longevity, a management services organization dedicated to the operation of longevity and functional wellness clinics across the United States. The company was established through the acquisition of the non-clinical assets of ThriveMD, PC, which is based in Denver and has another location in Vail, Colorado. Novellum aims to enhance access to advanced preventative care and health optimization services, such as hormone replacement therapy, peptide therapy, diagnostic labs, and regenerative medicine.

By focusing on a concierge-style approach, Novellum provides high-quality, science-backed aging care. This strategy not only addresses the root causes of health concerns but also enhances overall performance through a relationship-driven model. Such services position Novellum as a leader in a growing sector catering to wellness and longevity.

Industry Overview

The longevity and wellness industry has been increasingly prominent in the United States as consumer interest in preventative healthcare grows. The aging population is seeking more personalized and effective approaches to health managemen

View Source

Similar Deals

CPF Living Communities Rivertown Ridge

2025

Management Buyout / Buy-In (MBO) Residential & Long-Term Care United States of America
Revere Medical CareMax, Inc.

2024

Management Buyout / Buy-In (MBO) Managed Healthcare (NEC) United States of America
Turnspire Capital Partners Pharmachem Innovations

2024

Management Buyout / Buy-In (MBO) Pharmaceuticals (NEC) United States of America
Praesidian Capital Biologos Holdings, LLC

2024

Management Buyout / Buy-In (MBO) Biotechnology & Medical Research (NEC) United States of America
CUC Inc. Beyond Podiatry

2024

Management Buyout / Buy-In (MBO) Hospitals, Clinics & Primary Care Services United States of America
Safeguard DX Limited Safeguard Biosystems Holdings Limited

2024

Management Buyout / Buy-In (MBO) Bio Diagnostics & Testing United States of America

Capitala Group

invested in

Novellum Longevity

in 2025

in a Management Buyout / Buy-In (MBO) deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert